Management of Left Renal Artery Stenosis with Hypertension

Initial Medical Management Strategy

The European Society of Cardiology recommends initiating optimal medical therapy with at least 3 antihypertensive medications, including a diuretic, while avoiding ACE inhibitors and ARBs as first-line agents in unilateral stenosis, and reserving revascularization for specific high-risk scenarios after medical therapy failure 1, 2
The American College of Cardiology suggests that calcium channel blockers, beta-blockers, and diuretics should be the foundation of initial therapy for hypertension associated with renal artery stenosis, with the goal of achieving blood pressure control with maximally tolerated doses of at least 3 medications, one of which must be a diuretic 2

The American Heart Association indicates that ACE inhibitors and ARBs should be considered second-line or avoided initially in unilateral renal artery stenosis with two functioning kidneys, as 10-20% of patients will develop an unacceptable rise in serum creatinine, particularly with volume depletion 4

The European Heart Journal recommends considering renal artery angioplasty and stenting only in specific high-risk scenarios, including flash pulmonary edema, recurrent heart failure or unstable angina, resistant hypertension, and progressive renal function decline with uncontrolled hypertension 1, 2, 5
The American College of Cardiology suggests that stenosis must be hemodynamically significant, with ≥70% diameter stenosis, or 50-69% with post-stenotic dilatation and/or significant trans-stenotic pressure gradient, to consider revascularization 1, 5

The European Society of Cardiology recommends using duplex ultrasound as the first-line screening modality to identify increased peak systolic velocity in the renal artery, with confirmation by CT angiography or MR angiography often necessary before considering invasive procedures 4

The American Heart Association indicates that the most reliable predictor for effective blood pressure reduction is a short duration of pressure elevation, and most patients with moderate renovascular hypertension can be successfully managed with medical therapy, particularly with agents that block the renin-angiotensin system (if tolerated) 4